Advanced delivery of natural bioactive compounds for atopic dermatitis: a review of polymeric conjugates and nanocarriers

doi:10.1007/s13659-025-00585-w

Abstract

Abstract: Atopic dermatitis (AD) is a persistent, relapsing skin inflammatory disorder characterised by epidermal barrier dysfunction, immune system anomalies, and microbial dysbiosis. Current therapies encompass calcineurin inhibitors, topical corticosteroids, and synthetic drugs such as JAK inhibitors and biologics, which, despite their efficacy, have safety issues and constraints on prolonged use. Recently, natural bioactive compounds namely flavonoids, polyphenols, and terpenoids have garnered interest for their anti-inflammatory, antioxidant, and skin-barrier-repairing characteristics. Recent studies emphasise the incorporation of these bioactive compounds into hydrophilic/hydrophobic polymeric conjugates and nanocarrier systems to promote skin distribution, increase efficacy, and minimise systemic adverse effects. This study encapsulates traditional and innovative medicines, highlights the promise of polymer-conjugated herbal formulations, and examines recent developments in nanotechnology and delivery technologies for AD management. The increasing interest in bioactive ingredient formulations and polymeric nanocarriers indicates a favourable shift towards safer, more effective, and patient-compliant treatment methodologies.

Key words: Atopic dermatitis, Bioactive compounds, Polymeric conjugates, Nanocarriers, Skin barrier, Anti-inflammatory therapy, Herbal formulations

摘要： Atopic dermatitis (AD) is a persistent, relapsing skin inflammatory disorder characterised by epidermal barrier dysfunction, immune system anomalies, and microbial dysbiosis. Current therapies encompass calcineurin inhibitors, topical corticosteroids, and synthetic drugs such as JAK inhibitors and biologics, which, despite their efficacy, have safety issues and constraints on prolonged use. Recently, natural bioactive compounds namely flavonoids, polyphenols, and terpenoids have garnered interest for their anti-inflammatory, antioxidant, and skin-barrier-repairing characteristics. Recent studies emphasise the incorporation of these bioactive compounds into hydrophilic/hydrophobic polymeric conjugates and nanocarrier systems to promote skin distribution, increase efficacy, and minimise systemic adverse effects. This study encapsulates traditional and innovative medicines, highlights the promise of polymer-conjugated herbal formulations, and examines recent developments in nanotechnology and delivery technologies for AD management. The increasing interest in bioactive ingredient formulations and polymeric nanocarriers indicates a favourable shift towards safer, more effective, and patient-compliant treatment methodologies.

关键词: Atopic dermatitis, Bioactive compounds, Polymeric conjugates, Nanocarriers, Skin barrier, Anti-inflammatory therapy, Herbal formulations

Jigar Vyas, Nensi Raytthatha, Puja Vyas, Sudarshan Singh, Bhupendra G. Prajapati. Advanced delivery of natural bioactive compounds for atopic dermatitis: a review of polymeric conjugates and nanocarriers[J]. Natural Products and Bioprospecting, 2026, 16(3): 33-33.

References

[1] Deng X, Li Q, Lu J, Liu Y, Li H, Liao Z, et al. 2D MOF@Fe₃O₄@rGO as magnetic solid-phase extraction and supercritical fluids chromatography-tandem mass spectrometry quantification of strigolactones stereoisomers in rice (Oryza sativa L.). Food Chem. 2025;479:143667. https://doi.org/10.1016/j.foodchem.2025.143667.
[2] Singh S, Syukri DM, Ushir YV, Mishra A, Ontong JC, Nwabor OF, et al. Post-operative wound healing efficacy of Eucalyptus camaldulensis phenolic-rich extracts incorporated hydrogel with enhanced antioxidant, antibacterial, and anti-inflammatory activities. J Polym Environ. 2025;33(2):814-39. https://doi.org/10.1007/s10924-024-03427-x.
[3] Mohite P, Puri A, Munde S, Ade N, Budar A, Singh AK, et al. Bioactive compound-fortified nanomedicine in the modulation of reactive oxygen species and enhancement of the wound healing process: a review. Pharmaceutics. 2025;17(7):855. https://doi.org/10.3390/pharmaceutics17070855.
[4] Abdelghany S, Tekko IA, Vora L, Larrañeta E, Permana AD, Donnelly RF. Nanosuspension-based dissolving microneedle arrays for intradermal delivery of curcumin. Pharmaceutics. 2019. https://doi.org/10.3390/pharmaceutics11070308.
[5] Eyerich K, Eyerich S. Immune response patterns in non-communicable inflammatory skin diseases. J Europ Academy Dermatol Venereol JEADV. 2018;32(5):692-703. https://doi.org/10.1111/jdv.14673.
[6] Chidrawar VR, Singh S, Jayeoye TJ, Dodiya R, Samee W, Chittasupho C. Porous swellable hypromellose composite fortified with Eucalyptus camaldulensis leaf hydrophobic/hydrophilic phenolic-rich extract to mitigate dermal wound infections. J Polym Environ. 2023;31(9):3841-56. https://doi.org/10.1007/s10924-023-02860-8.
[7] Singh S, Chidrawar VR, Hermawan D, Dodiya R, Samee W, Ontong JC, et al. Hypromellose highly swellable composite fortified with Psidium guajava leaf phenolic-rich extract for antioxidative, antibacterial, anti-inflammatory, anti-melanogenesis, and hemostasis applications. J Polym Environ. 2023;31(7):3197-214. https://doi.org/10.1007/s10924-023-02819-9.
[8] Ciążyńska M, Olejniczak-Staruch I, Sobolewska-Sztychny D, Narbutt J, Skibińska M, Lesiak A. Ultraviolet radiation and chronic inflammation-molecules and mechanisms involved in skin carcinogenesis: a narrative review. Life. 2021. https://doi.org/10.3390/life11040326.
[9] McKernan DP. Pattern recognition receptors as potential drug targets in inflammatory disorders. Adv Protein Chem Struct Biol. 2020;119:65-109. https://doi.org/10.1016/bs.apcsb.2019.09.001.
[10] Lugović-Mihić L, Barac E, Tomašević R, Parać E, Zanze L, Ljevar A, et al. Atopic dermatitis-related problems in daily life, goals of therapy and deciding factors for systemic therapy: a review. Pharmaceuticals. 2024. https://doi.org/10.3390/ph17111455.
[11] Kim Y, Park K, Kim MS. Recent advances in polymer-based drug delivery systems for atopic dermatitis: enhancing therapeutic efficacy and outcomes. Mater Today Bio. 2025;35:102517. https://doi.org/10.1016/j.mtbio.2025.102517.
[12] Gittler JK, Shemer A, Suárez-Fariñas M, Fuentes-Duculan J, Gulewicz KJ, Wang CQ, et al. Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol. 2012;130(6):1344-54. https://doi.org/10.1016/j.jaci.2012.07.012.
[13] Moyle M, Cevikbas F, Harden JL, Guttman-Yassky E. Understanding the immune landscape in atopic dermatitis: the era of biologics and emerging therapeutic approaches. Exp Dermatol. 2019;28(7):756-68. https://doi.org/10.1111/exd.13911.
[14] Silverberg JI, Kantor R. The role of interleukins 4 and/or 13 in the pathophysiology and treatment of atopic dermatitis. Dermatol Clin. 2017;35(3):327-34. https://doi.org/10.1016/j.det.2017.02.005.
[15] Patrick MT, Zhang H, Wasikowski R, Prens EP, Weidinger S, Gudjonsson JE, et al. Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies. J Allergy Clin Immunol. 2021;147(3):857-869.e857. https://doi.org/10.1016/j.jaci.2021.01.006.
[16] Sidbury R, Kodama S. Atopic dermatitis guidelines: diagnosis, systemic therapy, and adjunctive care. Clin Dermatol. 2018;36(5):648-52. https://doi.org/10.1016/j.clindermatol.2018.05.008.
[17] Schneider S, Li L, Zink A. The new era of biologics in atopic dermatitis: a review. Dermatol Pract Conceptual. 2021;11(4):e2021144. https://doi.org/10.5826/dpc.1104a144.
[18] Bai R, Zheng Y, Dai X. Atopic dermatitis: diagnosis, molecular pathogenesis, and therapeutics. Mol Biomed. 2025;6(1):71. https://doi.org/10.1186/s43556-025-00313-3.
[19] Kakkar V, Saini K, Singh KK. Challenges of current treatment and exploring the future prospects of nanoformulations for treatment of atopic dermatitis. Pharmacol Rep. 2023;75(5):1066-95. https://doi.org/10.1007/s43440-023-00510-3.
[20] Abędź N, Pawliczak R. Efficacy and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis: meta-analysis of randomized clinical trials. Postepy Dermatol Alergol. 2019;36(6):752-9. https://doi.org/10.5114/ada.2019.91425.
[21] Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: Section. 2.Management and treatment of atopic dermatitis with topical therapies. J Am Academy Dermatol. 2014;71(1):116-32. https://doi.org/10.1016/j.jaad.2014.03.023.
[22] Simon D. Systemic therapy of atopic dermatitis in children and adults. Curr Probl Dermatol. 2011;41:156-64. https://doi.org/10.1159/000323309.
[23] Védie AL, Ezzedine K, Amazan E, Boralevi F, Milpied B, Taïeb A, et al. Long-term use of systemic treatments for moderate-to-severe atopic dermatitis in adults: a monocentric retrospective study. Acta Derm Venereol. 2016;96(6):802-6. https://doi.org/10.2340/00015555-2389.
[24] David E, Ungar B, Renert-Yuval Y, Facheris P, Del Duca E, Guttman-Yassky E. The evolving landscape of biologic therapies for atopic dermatitis: present and future perspective. Clini Exp Allergy J British Soc Allergy Clin Immunol. 2023;53(2):156-72. https://doi.org/10.1111/cea.14263.
[25] Kychygina A, Cassagne M, Tauber M, Galiacy S, Paul C, Fournié P, et al. Dupilumab-associated adverse events during treatment of allergic diseases. Clin Rev Allergy Immunol. 2022;62(3):519-33. https://doi.org/10.1007/s12016-022-08934-0.
[26] de Wijs LEM, van der Waa JD, de Jong PHP, Hijnen DJ. Acute arthritis and arthralgia as an adverse drug reaction to dupilumab. Clin Exp Dermatol. 2020;45(2):262-3. https://doi.org/10.1111/ced.14050.
[27] Kwon CY, Lee B, Kim S, Lee J, Park M, Kim N. Effectiveness and safety of herbal medicine for atopic dermatitis: an overview of systematic reviews. Evid Based Complement Alternat Med. 2020;2020:4140692. https://doi.org/10.1155/2020/4140692.
[28] Fehrenbach GW, Sheils K, Silva MJ, Walshe J, Madden L, Major I, et al. Anti-inflammatory and regenerative properties of herbal extracts: wound management in equine models. Drug Target Insights. 2025;19:41-8. https://doi.org/10.33393/dti.2025.3499.
[29] Sarkar S, Singh RP, Bhattacharya G. Exploring the role of Azadirachta indica (neem) and its active compounds in the regulation of biological pathways: an update on molecular approach. 3 Biotech. 2021;11(4):178. https://doi.org/10.1007/s13205-021-02745-4.
[30] Baby AR, Freire TB, Marques GdA, Rijo P, Lima FV, Carvalho JCMd, et al. Azadirachta indica (Neem) as a potential natural active for dermocosmetic and topical products: a narrative review. Cosmetics. 2022;9(3):58. https://doi.org/10.3390/cosmetics9030058.
[31] Gupta M, Singh S. Borago officinalis Linn. An important medicinal plant of Mediterranean region: review. Int J Pharm Sci Rev Res. 2010;5:27-34.
[32] Ezzaitouni M, Chileh-Chelh T, Rincón-Cervera MÁ, Gómez-Mercado F, Benteima H, López-Ruiz R, et al. Biocompounds and bioactivities of selected Greek Boraginaceae seeds. Appl Sci. 2024. https://doi.org/10.3390/app14146026.
[33] Asadi-Samani M, Bahmani M, Rafieian-Kopaei M. The chemical composition, botanical characteristic and biological activities of Borago officinalis: a review. Asian Pac J Trop Med. 2014;7:S22-28. https://doi.org/10.1016/s1995-7645(14)60199-1.
[34] Srivastava JK, Shankar E, Gupta S. Chamomile: a herbal medicine of the past with bright future. Mol Med Rep. 2010;3(6):895-901. https://doi.org/10.3892/mmr.2010.377.
[35] Evangelista MT, Abad-Casintahan F, Lopez-Villafuerte L. The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial. Int J Dermatol. 2014;53(1):100-8. https://doi.org/10.1111/ijd.12339.
[36] Cristea AM, Smeu A, Cîmpeanu IA, Iftode A, Liga S, Tchiakpe-Antal DS, et al. Biological effects of Rosaceae species in skin disorders-an up-to-date overview. Plants. 2025. https://doi.org/10.3390/plants14111605.
[37] de Macedo LM, Santos ÉM, Militão L, Tundisi LL, Ataide JA, Souto EB, Mazzola PG (2020) Rosemary (Rosmarinus officinalis L., syn Salvia rosmarinus Spenn.) and Its Topical Applications: A Review. Plants 9 (5). https://doi.org/10.3390/plants9050651
[38] Saad B. Immunomodulatory and anti-inflammatory properties of honey and bee products. Immuno. 2025. https://doi.org/10.3390/immuno5020019.
[39] Rakha A, Umar N, Rabail R, Butt MS, Kieliszek M, Hassoun A, et al. Anti-inflammatory and anti-allergic potential of dietary flavonoids: a review. Biomed Pharmacother. 2022;156:113945. https://doi.org/10.1016/j.biopha.2022.113945.
[40] Mutha RE, Tatiya AU, Surana SJ. Flavonoids as natural phenolic compounds and their role in therapeutics: an overview. Future J Pharm Sci. 2021;7(1):25. https://doi.org/10.1186/s43094-020-00161-8.
[41] Salazar J, Ortega Á, Pérez JL, Garrido B, Santeliz R, Galbán N, et al. Role of polyphenols in dermatological diseases: exploring pharmacotherapeutic mechanisms and clinical implications. Pharmaceuticals. 2025. https://doi.org/10.3390/ph18020247.
[42] Di Salvo E, Gangemi S, Genovese C, Cicero N, Casciaro M. Polyphenols from Mediterranean plants: biological activities for skin photoprotection in atopic dermatitis, psoriasis, and chronic urticaria. Plants. 2023. https://doi.org/10.3390/plants12203579.
[43] Choy YJ, Kim GR, Baik HU. Inhibitory effects of naringenin on LPS-induced skin inflammation by NF-κB regulation in human dermal fibroblasts. Curr Issues Mol Biol. 2024;46(9):9245-54. https://doi.org/10.3390/cimb46090546.
[44] He SM, Chan E, Zhou SF. ADME properties of herbal medicines in humans: evidence, challenges and strategies. Curr Pharm Des. 2011;17(4):357-407. https://doi.org/10.2174/138161211795164194.
[45] Saini K, Modgill N, Singh KK, Kakkar V. Tetrahydrocurcumin lipid nanoparticle based gel promotes penetration into deeper skin layers and alleviates atopic dermatitis in 2,4-Dinitrochlorobenzene (DNCB) mouse model. Nanomaterials. 2022. https://doi.org/10.3390/nano12040636.
[46] Sharma S, Sethi GS, Naura AS. Curcumin ameliorates ovalbumin-induced atopic dermatitis and blocks the progression of atopic march in mice. Inflammation. 2020;43(1):358-69. https://doi.org/10.1007/s10753-019-01126-7.
[47] Rawal RC, Shah BJ, Jayaraaman AM, Jaiswal V. Clinical evaluation of an Indian polyherbal topical formulation in the management of eczema. J Alternative Compl Medicine. 2009;15(6):669-72. https://doi.org/10.1089/acm.2008.0508.
[48] Suryawati N, Wardhana M, I Made B, Jawi M. Moisturizing nanoemulgel of turmeric (Curcuma longa) rhizome extract ameliorates atopic dermatitis-like skin lesions in mice model through thymic stromal lymphopoietin, interleukin-13, and interleukin-17. Biomol Health Sci J. 2022;5:81. https://doi.org/10.4103/bhsj.bhsj_26_22.
[49] Chiu YH, Wu YW, Hung JI, Chen MC. Epigallocatechin gallate/L-ascorbic acid-loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis. Acta Biomater. 2021;130:223-33. https://doi.org/10.1016/j.actbio.2021.05.032.
[50] Shen C, Shen B, Zhu J, Yuan H, Hu J. Topical delivery of pluronic F127/TPGS mixed micelles-based hydrogel loaded with glycyrrhizic acid for atopic dermatitis treatment. Drug Dev Ind Pharm. 2022;47:1-18. https://doi.org/10.1080/03639045.2022.2077957.
[51] Saeedi M, Morteza-Semnani K, Ghoreishi MR. The treatment of atopic dermatitis with licorice gel. J Dermatolog Treat. 2003;14(3):153-7. https://doi.org/10.1080/09546630310014369.
[52] Panahi Y, Rastgar N, Zamani A, Sahebkar A. Comparing the therapeutic effects of Aloe vera and olive oil combination cream versus topical betamethasone for atopic dermatitis: a randomized double-blind clinical trial. J Pharmacopuncture. 2020;23(3):173-8. https://doi.org/10.3831/kpi.2020.23.3.173.
[53] Na K, Lkhagva-Yondon E, Kim M, Lim YR, Shin E, Lee CK, et al. Oral treatment with Aloe polysaccharide ameliorates ovalbumin-induced atopic dermatitis by restoring tight junctions in skin. Scand J Immunol. 2020;91(3):e12856. https://doi.org/10.1111/sji.12856.
[54] Gupta D, Sanyogita K, Manigauha A. Novel formulation of Aloe vera and Quercetin in the management of dermal disease: eczema. Journal of Pharmaceuticsand Drug Research. 2021;4(2):480-7.
[55] Ratna Dewanti IDA, Susilawati I, Lestari P, Budirahardjo R, Wulandari E, Widi R, et al. Aquoeous extract of neem leaves (Azadirachta indica) decrease expression of immunoglbulin E (IgE) and interleukin 4 (IL-4) in gingiva tissue of BALB/c mice injected by ovalbumine. KnE Life Sci. 2017;3:413. https://doi.org/10.18502/kls.v3i6.1150.
[56] Xu J, Hu H, Qian X, Zhang D, Chen G, Zhang F, et al. Therapeutic effects of chamomile volatile oil nanoemulsion/Bletilla striata polysaccharides gels on atopic dermatitis. Int J Biol Macromol. 2024;277:134404. https://doi.org/10.1016/j.ijbiomac.2024.134404.
[57] Kachel M, Krajewska M, Stryjecka M, Ślusarczyk L, Matwijczuk A, Rudy S, et al. Comparative analysis of phytochemicals and antioxidant properties of borage oil (Borago officinalis L.) and milk thistle (Silybum marianum Gaertn). Appl Sci. 2023. https://doi.org/10.3390/app13042560.
[58] Varma SR, Sivaprakasam TO, Arumugam I, Dilip N, Raghuraman M, Pavan KB, et al. In vitro anti-inflammatory and skin protective properties of virgin coconut oil. J Tradit Complement Med. 2019;9(1):5-14. https://doi.org/10.1016/j.jtcme.2017.06.012.
[59] Verma N, Chakrabarti R, Das RH, Gautam HK. Anti-inflammatory effects of shea butter through inhibition of iNOS, COX-2, and cytokines via the Nf-κB pathway in LPS-activated J774 macrophage cells. J Complement Integr Med. 2012. https://doi.org/10.1515/1553-3840.1574.
[60] Smith T, Rana RS, Missiaen P, Rose KD, Sahni A, Singh H, et al. High bat (Chiroptera) diversity in the Early Eocene of India. Naturwissenschaften. 2007;94(12):1003-9. https://doi.org/10.1007/s00114-007-0280-9.
[61] Malayeri AR, Salimi A, Iraji F, Sabbagh S, Shakerian N, Khaledi M. Investigating the effect of a herbal cream containing rose essence in an animal model of eczema. Avicenna J Phytomed. 2025;15(2):1070-81. https://doi.org/10.22038/ajp.2024.25132.
[62] Alangari AA, Morris K, Lwaleed BA, Lau L, Jones K, Cooper R, et al. Honey is potentially effective in the treatment of atopic dermatitis: clinical and mechanistic studies. Immunity, inflammation and disease. 2017;5(2):190-9. https://doi.org/10.1002/iid3.153.
[63] Al-Waili NS. Topical application of natural honey, beeswax and olive oil mixture for atopic dermatitis or psoriasis: partially controlled, single-blinded study. Complement Ther Med. 2003;11(4):226-34. https://doi.org/10.1016/s0965-2299(03)00120-1.
[64] Yeo IJ, Park JH, Jang JS, Lee DY, Park JE, Choi YE, et al. Inhibitory effect of Carnosol on UVB-induced inflammation via inhibition of STAT3. Arch Pharm Res. 2019;42(3):274-83. https://doi.org/10.1007/s12272-018-1088-1.
[65] Beken B, Serttas R, Yazicioglu M, Turkekul K, Erdogan S. Quercetin improves inflammation, oxidative stress, and impaired wound healing in atopic dermatitis model of human keratinocytes. Pediatr Allergy Immunol Pulmonol. 2020;33(2):69-79. https://doi.org/10.1089/ped.2019.1137.
[66] Liu C, Cheng X, Wu Y, Xu W, Xia H, Jia R, et al. Antioxidant activity of quercetin-containing liposomes-in-gel and its effect on prevention and treatment of cutaneous eczema. Pharmaceuticals. 2023. https://doi.org/10.3390/ph16081184.
[67] Hiragun M, Hiragun T, Oseto I, Uchida K, Yanase Y, Tanaka A, et al. Oral administration of β-carotene or lycopene prevents atopic dermatitis-like dermatitis in HR-1 mice. J Dermatol. 2016. https://doi.org/10.1111/1346-8138.13350.
[68] Preeti AJ, Badruddeen KMI, Ahmad M, Mishra S. Formulation and optimization of Kaempferol nanoemulsion-based gel for treating skin erythema using Box-Behnken statistical design. Lett Drug Des Discovery. 2025;22(8):100132. https://doi.org/10.1016/j.lddd.2025.100132.
[69] Nwabor OF, Singh S, Paosen S, Vongkamjan K, Voravuthikunchai SP. Enhancement of food shelf life with polyvinyl alcohol-chitosan nanocomposite films from bioactive Eucalyptus leaf extracts. Food Biosci. 2020;36:100609. https://doi.org/10.1016/j.fbio.2020.100609.
[70] Singh S, Nwabor OF, Syukri DM, Voravuthikunchai SP. Chitosan-poly(vinyl alcohol) intelligent films fortified with anthocyanins isolated from Clitoria ternatea and Carissa carandas for monitoring beverage freshness. Int J Biol Macromol. 2021;182:1015-25. https://doi.org/10.1016/j.ijbiomac.2021.04.027.
[71] Mohite P, Puri A, Munde S, Dave R, Khan S, Patil R, et al. Potential of chitosan/gelatin-based nanofibers in delivering drugs for the management of varied complications: a review. Polymers. 2025;17(4):435. https://doi.org/10.3390/polym17040435.
[72] Shah SR, Modi CD, Singh S, Mori DD, Soniwala MM, Prajapati BG. Recent advances in additive manufacturing of polycaprolactone-based scaffolds for tissue engineering applications: a comprehensive review. Regen Eng Transl Med. 2025;11(1):112-31. https://doi.org/10.1007/s40883-024-00351-3.
[73] Zhao W, Li J, Jin K, Liu W, Qiu X, Li C. Fabrication of functional PLGA-based electrospun scaffolds and their applications in biomedical engineering. Mater Sci Eng, C. 2016;59:1181-94. https://doi.org/10.1016/j.msec.2015.11.026.
[74] Rojas K, Verdugo-Molinares MG, Vallejo-Cardona AA. Use of encapsulating polymers of active compounds in the pharmaceutical and food industry. Food Chem Adv. 2024;4:100619. https://doi.org/10.1016/j.focha.2024.100619.
[75] Conte R, De Luca I, Valentino A, Cerruti P, Pedram P, Cabrera-Barjas G, et al. Hyaluronic acid hydrogel containing resveratrol-loaded chitosan nanoparticles as an adjuvant in atopic dermatitis treatment. J Funct Biomater. 2023. https://doi.org/10.3390/jfb14020082.
[76] Antoszewska M, Sokolewicz EM, Barańska-Rybak W. Wide use of hyaluronic acid in the process of wound healing—a rapid review. Scient Pharm. 2024. https://doi.org/10.3390/scipharm92020023.
[77] Wu Y, Zhou Z, Zhang M, Li S, Sun M, Song Z. Hollow manganese dioxide-chitosan hydrogel for the treatment of atopic dermatitis through inflammation-suppression and ROS scavenging. J Nanobiotechnology. 2023;21(1):432. https://doi.org/10.1186/s12951-023-02174-w.
[78] Hameed H, Ahmad SM, Khan MA, Nabi Mu, Shehzad R, Majeed I, et al. Chitosan as a multifunctional polymer in drug delivery systems for diabetic wound management. Polym Bull. 2025;82(11):5241-74. https://doi.org/10.1007/s00289-025-05758-8.
[79] Rao H, Tan JBL. Polysaccharide-based hydrogels for atopic dermatitis management: a review. Carbohydr Polym. 2025;349(Pt B):122966. https://doi.org/10.1016/j.carbpol.2024.122966.
[80] Tomić SL, Babić Radić MM, Vuković JS, Filipović VV, Nikodinovic-Runic J, Vukomanović M. Alginate-based hydrogels and scaffolds for biomedical applications. Mar Drugs. 2023. https://doi.org/10.3390/md21030177.
[81] Rajkumar J, Chandan N, Lio P, Shi V. The skin barrier and moisturization: function, disruption, and mechanisms of repair. Skin Pharmacol Physiol. 2023;36(4):174-85. https://doi.org/10.1159/000534136.
[82] Dias JR, Sousa A, Augusto A, Bártolo PJ, Granja PL. Electrospun polycaprolactone (PCL) degradation: an in vitro and in vivo study. Polymers. 2022. https://doi.org/10.3390/polym14163397.
[83] Park EJ, Yap BLH, Wang X, Poh QZ, Tan CH, Koh LF, et al. Bioactive PLGA polymer nanoparticle loaded gels for atopic dermatitis treatment. Discover Appl Sci. 2025;7(4):304. https://doi.org/10.1007/s42452-025-06688-w.
[84] Vora LK, Sabri AH, Naser Y, Himawan A, Hutton ARJ, Anjani QK, et al. Long-acting microneedle formulations. Adv Drug Deliv Rev. 2023;201:115055. https://doi.org/10.1016/j.addr.2023.115055.
[85] Wang M, Bai J, Shao K, Tang W, Zhao X, Lin D, et al. Poly(vinyl alcohol) hydrogels: the old and new functional materials. Int J Polym Sci. 2021;2021(1):2225426. https://doi.org/10.1155/2021/2225426.
[86] Ibrahim M, Ramadan E, Elsadek N, Emam S, Shimizu T, Ando H, et al. Polyethylene glycol (PEG): the nature, immunogenicity, and role in the hypersensitivity of PEGylated products. J Control Release. 2022;351:215-30. https://doi.org/10.1016/j.jconrel.2022.09.031.
[87] Lee S, Kim A, Koo J, Kim Y, Choi S, Cho JC. Injectable PEG-PCL-PEG copolymers for skin rejuvenation: in vitro cell studies to in vivo collagen induction. Polymers. 2025. https://doi.org/10.3390/polym17141892.
[88] Try C, Abdel-Mottaleb MMA, Béduneau A, Moulari B, Pazart L, Vidal C, et al. Polymeric nanoparticles’ accumulation in atopic dermatitis: clinical comparison between healthy, non-lesional, and lesional skin. Pharmaceutics. 2023. https://doi.org/10.3390/pharmaceutics15071927.
[89] Jeong H, Kim H-L, Kim H, Lee M-S, Cho J-M, Park CL, et al. Conjugated polymer of multi-arm-PEG and dimethylsiloxane (CPMD) for the effective transdermal delivery of deoxycholic acid for fat reduction. Chem Eng J. 2025;505:159405. https://doi.org/10.1016/j.cej.2025.159405.
[90] Hoy SM. Crisaborole ointment 2%: a review in mild to moderate atopic dermatitis. Am J Clin Dermatol. 2017;18(6):837-43. https://doi.org/10.1007/s40257-017-0327-4.
[91] Porter E, O’Connor C, Murphy M. Re-engagement, quality of life, and burden of treatment in adults on dupilumab for severe atopic dermatitis—a mixed methods study. Skin Health and Disease. 2024;4(4):ski2.372. https://doi.org/10.1002/ski2.372.
[92] Damiani G, Eggenhöffner R, Pigatto PDM, Bragazzi NL. Nanotechnology meets atopic dermatitis: current solutions, challenges and future prospects. Insights and implications from a systematic review of the literature. Bioact Mater. 2019;4:380-6. https://doi.org/10.1016/j.bioactmat.2019.11.003.
[93] Slavkova M, Lazov C, Spassova I, Kovacheva D, Tibi IP, Stefanova D, et al. Formulation of budesonide-loaded polymeric nanoparticles into hydrogels for local therapy of atopic dermatitis. Gels. 2024. https://doi.org/10.3390/gels10010079.
[94] Pan J, Han X, Yuan P, Xu Y, Wang W, Zhang Z, et al. A multifunctional hydrogel microneedle patch for treatment of atopic dermatitis. ACS Appl Mater Interfaces. 2025;17(20):29341-51. https://doi.org/10.1021/acsami.5c03594.
[95] Chen X, Li P, Kang Y, Zeng X, Xie Y, Zhang Y, et al. Preparation of temperature-sensitive Xanthan/NIPA hydrogel using citric acid as crosslinking agent for bisphenol A adsorption. Carbohydr Polym. 2019;206:94-101. https://doi.org/10.1016/j.carbpol.2018.10.092.
[96] Siriyong T, Phungtammasan S, Jansorn S, Chonsongkram N, Chanwanitsakul S, Subhadhirasakul S, et al. Traditional Thai herbal medicine as an alternative treatment for refractory chronic eczema. Explore. 2020;16(4):242-9. https://doi.org/10.1016/j.explore.2019.10.001.
[97] Chan BC, Hon KL, Leung PC, Sam SW, Fung KP, Lee MY, et al. Traditional Chinese medicine for atopic eczema: PentaHerbs formula suppresses inflammatory mediators release from mast cells. J Ethnopharmacol. 2008;120(1):85-91. https://doi.org/10.1016/j.jep.2008.07.034.
[98] Kirby AJ, Schmidt RJ. The antioxidant activity of Chinese herbs for eczema and of placebo herbs-I. J Ethnopharmacol. 1997;56(2):103-8. https://doi.org/10.1016/s0378-8741(97)01510-9.
[99] Park BK, Park YC, Jung IC, Kim SH, Choi JE, Park S, et al. Oral administration of SSC201, a medicinal herbal formula, suppresses atopic dermatitis-like skin lesions. J Med Food. 2014;17(4):496-504. https://doi.org/10.1089/jmf.2013.2941.
[100] Tsang MS, Jiao D, Chan BC, Hon KL, Leung PC, Lau CB, et al. Anti-inflammatory activities of Pentaherbs formula, berberine, gallic acid and chlorogenic acid in atopic dermatitis-like skin inflammation. Molecules. 2016;21(4):519. https://doi.org/10.3390/molecules21040519.
[101] Wu XX, Siu WS, Wat CL, Chan CL, Koon CM, Li X, et al. Effects of topical application of a tri-herb formula on inflammatory dry-skin condition in mice with oxazolone-induced atopic dermatitis. Phytomedicine. 2021;91:153691. https://doi.org/10.1016/j.phymed.2021.153691.
[102] Iraji FZB, Mousavi A, Mousavi F. Efficacy of a herbal cream formulation incorporating Calendula officinalis, Glycyrrhiza glabra, Curcuma longa, and Fumaria parviflora versus topical mometasone in the management of atopic dermatitis. J Skin Stem Cell. 2024;11(4):e157540.
[103] Nam YK, Kim MH, Ha IJ, Yang WM. Derma-Hc, a new developed herbal formula, ameliorates cutaneous lichenification in atopic dermatitis. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms22052359.
[104] Khalighi N, Jabbari-Azad F, Barzegar-Amini M, Tavakkol-Afshari J, Layegh P, Salari R. Impact of Althaea officinalis extract in patients with atopic eczema: a double-blind randomized controlled trial. Clin Phytoscience. 2021;7(1):73. https://doi.org/10.1186/s40816-021-00306-z.
[105] Ma T, Chai Y, Li S, Sun X, Wang Y, Xu R, et al. Efficacy and safety of Qinzhuliangxue decoction for treating atopic eczema: a randomized controlled trial. Ann Palliat Med. 2020;9(3):870-82. https://doi.org/10.21037/apm.2020.04.17.
[106] Oláh A, Szabó-Papp J, Soeberdt M, Knie U, Dähnhardt-Pfeiffer S, Abels C, et al. Echinacea purpurea-derived alkylamides exhibit potent anti-inflammatory effects and alleviate clinical symptoms of atopic eczema. J Dermatol Sci. 2017;88(1):67-77. https://doi.org/10.1016/j.jdermsci.2017.05.015.
[107] Zhu L, Li XJ, Gu C, Gao Y, Zhang CS, Wang LY, et al. Mongolian medicine wenguanmu ointment treats eczema by inhibiting the CKLF-1/NF-κB pathway. J Ethnopharmacol. 2023;313:116549. https://doi.org/10.1016/j.jep.2023.116549.
[108] Xuan M, Guo X, Li H, Xie T, Mo X, Wen Z. The Chinese herbal formula Huoxiang Zhengqi for atopic dermatitis with dampness pattern (CHARM): a study protocol for a double-blinded randomized controlled trial. Trials. 2021;22(1):67. https://doi.org/10.1186/s13063-020-05014-6.
[109] Gu SX, Zhang AL, Coyle ME, Mo X, Lenon GB, Cranswick NE, et al. Chinese herbal medicine granules (PTQX) for children with moderate to severe atopic eczema: study protocol for a randomised controlled trial. Trials. 2015;16(1):294. https://doi.org/10.1186/s13063-015-0806-y.
[110] Silverberg JI, Bunick CG, Hong HC-h, Mendes-Bastos P, Stein Gold L, Costanzo A, et al. Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up). Br J Dermatol. 2025;192(1):36-45. https://doi.org/10.1093/bjd/ljae404.